Welcome to our dedicated page for Cronos Group SEC filings (Ticker: CRON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Cronos Group Inc. (CRON), a cannabinoid-focused company listed on NASDAQ and the Toronto Stock Exchange. As a foreign private issuer incorporated in British Columbia, Canada, Cronos files reports with the SEC under Commission File Number 001-38403, giving investors structured insight into its operations, governance and financial condition.
Cronos’ SEC disclosure includes current reports on Form 8-K, which the company uses to announce material events. Recent 8-K filings have covered quarterly financial results, such as press releases for the second and third quarters of 2025, and corporate governance matters, including the appointment and subsequent termination of the company’s principal accounting officer and the results of the 2025 Annual Meeting of Shareholders. These filings provide detail on topics like voting outcomes for director elections, advisory votes on executive compensation and the appointment of the independent auditor.
Through this filings page, users can also review Cronos’ periodic reports (such as annual and quarterly filings referenced in its 8-Ks) to understand trends in revenue, gross profit, adjusted EBITDA and other metrics the company discusses in its earnings materials. The filings describe elements of Cronos’ business, including its cannabis brands, international operations and investments such as its interest in Cronos Growing Company Inc. (Cronos GrowCo).
Stock Titan enhances these documents with AI-powered summaries that highlight key points from lengthy filings, helping readers quickly identify important changes in financial performance, governance or strategy. Real-time updates from the EDGAR system ensure that new Cronos 8-Ks, 10-K equivalents for foreign issuers, 10-Q equivalents and proxy materials are added as they are filed, while insider transaction reports on Form 4, if applicable, can be used to monitor share dealings by directors and officers.
By combining Cronos’ official SEC filings with AI-generated explanations, this page is designed to make the company’s regulatory disclosures more accessible to investors, analysts and other stakeholders.
Cronos Group Inc. officer Anna Shlimak exercised restricted stock units that converted into 28,429 common shares on March 19, 2026. These RSUs represent the first vesting portion of an 85,297-unit grant awarded on March 19, 2025, scheduled to vest in three substantially equal annual installments.
To cover related tax obligations, 9,767 common shares were withheld and disposed of at a price of $2.54 per share. After these compensation-related transactions, Shlimak directly holds 358,595 common shares of Cronos Group Inc., with no remaining derivative position reported in this filing.
Cronos Group Inc. officer Terrence Gregory Joseph Doucet exercised 23,897 restricted stock units into an equal number of common shares. These RSUs were part of a grant of 71,691 units awarded on March 15, 2023, vesting in three substantially equal annual installments.
To cover tax obligations related to the vesting, 12,276 common shares were withheld at a price of C$3.44 per share. After these transactions, Doucet directly holds 105,190 common shares and 184,408 restricted stock units, showing this was primarily a compensation-related vesting and tax-withholding event rather than an open-market trade.
Cronos Group Inc. officer Arye Weigensberg reported compensation-related equity transactions. On March 16, 2026, he received a grant of 12,245 restricted stock units (RSUs), each representing a right to receive one common share, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
On March 15, 2026, he exercised 24,236 RSUs into an equal number of common shares, reflecting the vesting of part of an earlier RSU grant made on March 15, 2023. Following these transactions, he directly owns 208,437 common shares and holds 157,537 RSUs. These are grants and conversions, not open-market purchases or sales.
Cronos Group Inc. director and officer Michael Ryan Gorenstein exercised restricted stock units that converted into common shares as part of a prior equity award. He exercised 324,540 RSUs, each representing one common share, and received an equivalent number of common shares at a stated exercise price of $0.00 per share.
To satisfy tax obligations on this vesting event, 127,706 common shares were withheld at a value of $2.50 per share, leaving him with 13,213,017 common shares held directly after the transactions. Following the RSU exercise, his remaining restricted stock unit balance was 1,912,426 RSUs. These RSUs come from a 973,618-unit grant awarded on March 15, 2023, vesting in three annual installments.
Cronos Group Inc. officer Anna Shlimak reported a routine equity compensation event involving restricted stock units (RSUs). On March 15, 2026, she exercised 45,226 RSUs into an equal number of common shares at a conversion price of $0.00 per share.
In connection with this vesting, 16,354 common shares were disposed of at $2.50 per share to cover tax obligations, a tax-withholding transaction rather than an open‑market sale. After these transactions, she directly holds 339,933 common shares. The RSUs were part of a 135,678‑unit grant awarded on March 15, 2023, scheduled to vest in three substantially equal annual installments.
Cronos Group Inc.’s Chief Growth Officer Jeffrey David Jacobson exercised restricted stock units into common shares as part of his equity compensation. He converted 59,191 RSUs into 59,191 common shares at a stated price of $0.00 per share, increasing his direct common share holdings.
To cover tax obligations related to this vesting, 22,552 common shares were withheld at $2.50 per share in a tax-withholding disposition, which is not an open-market sale. After these transactions, Jacobson directly owns 484,681 common shares. The RSUs come from a 177,573-unit grant awarded on March 15, 2023, vesting in three substantially equal annual installments.
Cronos Group Inc. officer Buggy Shannon exercised restricted stock units into common shares as part of equity compensation. On March 15, 2026, 20,938 RSUs were converted into 20,938 common shares at a conversion price of $0.00 per share.
To cover tax obligations on this vesting event, 9,202 common shares were withheld at $2.50 per share, which is recorded as a tax-withholding disposition rather than an open-market sale. After these transactions, Shannon directly holds 166,879 common shares of Cronos Group Inc.
The RSUs stem from a March 15, 2023 grant of 62,814 units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. The filing shows no remaining derivative securities related to this grant.
Cronos Group Inc. officer Adam Wagner reported an exercise of restricted stock units that converted into common shares. On March 12, 2026, he exercised 15,715 RSUs, each representing one common share, at a stated price of $0.00 per share, receiving 15,715 common shares.
After this RSU conversion, Wagner directly holds 73,150 common shares and 186,106 restricted stock units. The filing also notes a prior grant of 47,144 RSUs on March 12, 2025, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date, underscoring that this is part of an ongoing equity compensation program rather than an open-market purchase.
Cronos Group Inc. officer Arye Weigensberg exercised restricted stock units into common shares. On March 12, 2026, he converted 26,825 RSUs into 26,825 common shares at no cash exercise price, reflecting a compensation-related event rather than an open‑market trade.
Following the transaction, he directly holds 184,201 common shares. Footnotes explain that each RSU represents a right to receive one common share and reference a prior grant of 80,474 RSUs vesting in three substantially equal annual installments beginning on the first anniversary of the March 12, 2025 grant date.
Cronos Group Inc. director and officer Michael Ryan Gorenstein exercised restricted stock units into common shares and had a portion withheld for taxes. He converted 339,879 RSUs into 339,879 common shares. Of these, 132,991 common shares were withheld at $2.56 per share to cover tax obligations, a non‑market disposition.
After these transactions, he directly holds 13,016,183 common shares and no remaining derivative position from this RSU grant. The RSUs exercised are part of a larger award of 1,019,736 RSUs that vest in three substantially equal annual installments beginning on the first anniversary of the March 12, 2025 grant date.